Eye Abnormalities clinical trials
The registry lists 24 studies for Eye Abnormalities across more than 10 countries. 4 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-09-01.
Status
- Completed
- 11
- Terminated
- 3
- Status unknown
- 3
- Recruiting
- 3
- Active, not recruiting
- 2
- Withdrawn
- 1
Phase
- Phase 2
- 7
- Phase 3
- 4
- Phase 1
- 2
Where
- United States
- 13
- United Kingdom
- 7
- Germany
- 6
- France
- 6
- Netherlands
- 5
- Brazil
- 5
Who runs them
Laboratoires Thea (6) · Heidelberg Engineering GmbH (2) · ProQR Therapeutics (2) · TC Erciyes University (1) · Topcon Corporation (1) · Westat (1) · Instituto de Olhos de Goiania (1) · National Eye Institute (NEI) (1)
Studies
Recruiting first, then most recently updated. Showing 24 of 24 — search for more.
- Study to Evaluate the Long-Term Safety of Ultevursen in Participants With Retinitis Pigmentosa (RP) Due to Mutations in Exon 13 of the USH2A GeneNot yet recruitingNCT07796646Phase 2
- Study to Evaluate Sepofarsen in Subjects With Leber Congenital Amaurosis (LCA) Type 10 (HYPERION)RecruitingNCT06891443Phase 39 countries
- Modeling Ocular Developmental Diseases From 3D Cultures of Optic Vesicle Organoids Derived From hiPSCs of Patients With Ocular MalformationsRecruitingNCT064087011 country
- Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at SanfordRecruitingNCT017931682 countries
- Study to Evaluate Ultevursen in Subjects With Retinitis Pigmentosa (RP) Due to Mutations in Exon 13 of the USH2A GeneActive, not recruitingNCT06627179Phase 210 countries
- The Heidelberg Engineering BI US Evaluation StudyCompletedNCT035783021 country
- Agreement and Precision StudyCompletedNCT067334281 country
- Extension Study to Study PQ-110-001 (NCT03140969)TerminatedNCT03913130Phase 1/22 countries
- Study to Evaluate the Efficacy Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene With Early to Moderate Vision Loss (Celeste)TerminatedNCT05176717Phase 2/32 countries
- Study to Evaluate the Efficacy Safety and Tolerability of Ultevursen in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene (Sirius)TerminatedNCT05158296Phase 2/34 countries
- Effects of a Combination of Polyphenol-rich Extracts on the Protection of Retinal Cells Against Blue Light in the Prevention of Ocular DiseasesCompletedNCT06004570Not applicable1 country
- Biomarker for Maroteaux-Lamy Disease (BioMaroteaux)WithdrawnNCT014586134 countries
- Reading Problems Associated With Central Nervous System (CNS) Pathologies.CompletedNCT049377251 country
- The Heidelberg Engineering ANTERION Imaging Agreement StudyCompletedNCT040688181 country
- Natural History Study of CEP290-Related Retinal DegenerationCompletedNCT033960424 countries
- International Cohort Study of Children Born to Women Infected With Zika Virus During PregnancyCompletedNCT041187384 countries
- Relation Between Oculocardiac Reflex and LaryngospasmStatus unknownNCT053398801 country
- Study to Evaluate Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon 13 of the USH2A GeneCompletedNCT03780257Phase 1/23 countries
- A Study to Evaluate Efficacy, Safety, Tolerability and Exposure After a Repeat-dose of Sepofarsen (QR-110) in LCA10 (ILLUMINATE)Active, not recruitingNCT03913143Phase 2/39 countries
- Independent Prescribing Optometrists in Acute Ophthalmic ServicesCompletedNCT025850631 country
- The Stroke Vision App: A Screening Tool for Visual StrokeStatus unknownNCT02539381Not applicable1 country
- Epidemiological Profile of Ophthalmological Care in the Public Service in BrazilCompletedNCT017404661 country
- Riboflavin Corneal Crosslinking for Brittle Cornea Syndrome and Ehlers-Danlos Syndrome Type VIStatus unknownNCT01307527Not applicable1 country
- Abnormalities of the Eye's Anterior Chamber, Iris, Cornea and LensCompletedNCT000011611 country